Back to search

Denmark· DK-28107095724

Empagliflozin "Denk"

A empagliflozin product containing empagliflozin, registered in Denmark by Denk Pharma GmbH & Co KG. The same ATC class is registered in 16 of our 19 countries.

ATC A10BK03

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedEmpagliflozin "Denk"ATCA10BK03REGISTER NO.DK-28107095724PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Empagliflozin is registered in 16 of 19 countries.

Countries holding a registration under ATC A10BK03 (empagliflozin), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 9 of them publish a price we can compare per daily dose

Empagliflozin · ATC A10BK03

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of empagliflozin costs, country by country.

Normalised to the WHO defined daily dose (17.5 mg), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Empagliflozin · price per daily dose (17.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$3.80
  • IT Italy$2.95
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
Empagliflozin
Manufacturer
Denk Pharma GmbH & Co KG
Country
Denmark (DK)
ATC code
A10BK03
ATC class
Empagliflozin
Defined daily dose
17.5 mg, O
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28107095724

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

466 interactions on record for empagliflozin.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Empagliflozin · interactions on record

466 records

  • 1 severe
  • 425 moderate
  • 40 minor

Most severe, free to view

  • SucralfateA02BX02moderate
  • PapaverineA03AD01moderate
  • ThiethylperazinA04AB03moderate
  • TriflupromazinA04AD06moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/95318eca-f79c-4d64-b2d3-45cd76a4d084
GET /v1/drugs/95318eca-f79c-4d64-b2d3-45cd76a4d084?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "filmovertrukne tabletter",
  "source": "dkma",
  "strength": "25 mg",
  "auth_role": "RMS",
  "dk_drugid": "28107095724",
  "substance": "Empagliflozin",
  "auth_procedure": "Decentral procedure",
  "in_medicinpriser": false,
  "registration_date_serial": "45973"
}

See everything about empagliflozin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.